Julia Jacques
Primary Care · Boynton Beach, FLNPI 1073022380
Payments from drug & device makers
Across 78 payments — averaging $25.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$427
- Novo Nordisk$309
- Pfizer$294
- Johnson & Johnson$155
- Astellas Pharma US Inc$90
- Sumitomo Pharma America, Inc.$89
- plus $616 from 17 others
What the payments were for
- Food & beverage$1,980100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $427 |
| Novo Nordisk | 12 | $309 |
| Pfizer | 13 | $294 |
| Johnson & Johnson | 8 | $155 |
| Astellas Pharma US Inc | 3 | $90 |
| Sumitomo Pharma America, Inc. | 4 | $89 |
| Amarin Pharma, Inc. | 5 | $87 |
| Lilly USA, LLC | 4 | $78 |
| Exact Sciences | 3 | $75 |
| GSK | 3 | $63 |
| Smith+Nephew | 1 | $44 |
| Boehringer Ingelheim | 2 | $33 |
| AbbVie | 2 | $31 |
| Corcept Therapeutics | 1 | $28 |
| Eisai Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Merck | 1 | $19 |
| Amgen | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Biogen | 1 | $18 |
| Novartis | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,980 in reported general payments places this provider in the 80th percentile of 725 primary care providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 128 | $2,968 |
| Fluticasone Propionate | 140 | $2,389 |
| Valsartan | 46 | $1,219 |
| Methylprednisolone | 171 | $1,127 |
| Pantoprazole Sodium | 48 | $1,035 |
| Levothyroxine Sodium | 55 | $672 |
| Ipratropium Bromide | 15 | $578 |
| Azithromycin | 148 | $557 |
| Doxycycline Hyclate | 86 | $556 |
| Ciprofloxacin Hcl | 113 | $548 |
| Cefdinir | 36 | $502 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 25 | $409 |
| Rosuvastatin Calcium | 37 | $400 |
| Lisinopril | 35 | $336 |
| Amoxicillin | 107 | $335 |
Paid to pharmacies, not to this prescriber.
Other primary care in Boynton Beach
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Maria Rodriguez ReyesHialeah$31K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Yolanda PalmeroSaint Cloud$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
- Kristen DeasonTallahassee$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.